AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Carvitab 3.125 Tablet

Prescription Icon
Prescription Required

Marketer

ADN Life Sciences

Salt Composition

Carvedilol (3.125mg)

Overview Carvitab 3.125 Tablet

Cardiovasc 3.125mg tablets manage hypertension, angina pectoris, and congestive heart failure. Its mechanism involves vasodilation, improving cardiac blood flow. Reduced blood pressure mitigates stroke and myocardial infarction risk. Administer this medication with meals, following your physician's prescribed dosage and regimen. Consistent use is vital, even with symptom improvement or controlled blood pressure. Discontinue only under medical supervision to prevent condition exacerbation. Lifestyle modifications, such as regular physical activity, weight management, smoking cessation, moderate alcohol consumption, and a low-sodium diet (as directed), enhance treatment efficacy. While generally well-tolerated, potential side effects include vertigo, cephalalgia, dyspnea, and fatigue. Report persistent or bothersome adverse effects to your doctor. Prior to commencing therapy, inform your doctor of any pre-existing cardiac or renal conditions, and pregnant or lactating women should seek medical counsel before use.

Uses of Carvitab 3.125 Tablet

Managing elevated blood pressure | Addressing angina pectoris | Cardiac insufficiency management

Major Benefits of Carvitab 3.125 Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Carvitab 3.125 Tablet with a meal.

Common Side effects of Carvitab 3.125 Tablet:

  • Decreased blood pressure
  • Headache
  • Fatigue
  • Dizziness
  • Breathlessness

How to use Carvitab 3.125 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Carvitab 3.125 Tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.

How Carvitab 3.125 Tablet works:

Carvitab 3.125 mg tablets combine alpha and beta-blocking properties. This medication reduces heart rate and dilates blood vessels, thereby improving the heart's pumping efficiency.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol consumption while taking Carvitab 3.125 Tablet.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Carvitab 3.125 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Medical advice is recommended.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Lactation and Carvitab 3.125 mg tablets appear compatible. Available human data indicates minimal infant risk associated with this medication.

DrivingDrivingUNSAFE

Taking Carvitab 3.125 mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

Carvitab 3.125mg tablets can be used by patients with kidney disease without altering the prescribed dose. Nevertheless, disclosure of pre-existing kidney conditions to your physician is advised. Routine blood pressure monitoring is suggested to guide any necessary dosage modifications.

LiverLiverCAUTION

Patients with hepatic impairment should use Carvitab 3.125mg tablets cautiously, potentially requiring dosage modification. Medical advice is recommended. Carvitab 3.125mg tablets are contraindicated in individuals with severe liver dysfunction.

What if you forget to take Carvitab 3.125 Tablet :

Should you forget a Carvitab 3.125 Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Carvitab 3.125 Tablet

LabelValue
Pharmaceutical Category Carbazole-based compound with a propanol moiety.
Potential for Dependence None.
Medication Classification Heart-related
Mechanism of Action Combined alpha and beta adrenergic receptor antagonist

FAQs on Carvitab 3.125 Tablet

Consistent use of Carvitab 3.125mg tablets, as prescribed by your physician, is crucial. Abrupt cessation may result in chest pain or myocardial infarction. If discontinuation is necessary, your doctor will gradually reduce your dosage to minimize risks.
Fatigue and dizziness are potential side effects of Carvitab 3.125 Tablet, particularly at treatment initiation or following dose escalation. Refrain from driving or operating equipment if these effects are experienced.
Weight increase is a frequently reported side effect of Carvitab 3.125 Tablet, though not universally experienced. Patients using Carvitab 3.125 Tablet for congestive heart failure should report any weight gain or shortness of breath to their physician; these symptoms could indicate fluid buildup.
In rare instances, administering Carvitab 3.125 Tablet to patients with heart failure might negatively impact kidney function. The risk of kidney failure from Carvitab 3.125 Tablet is heightened in individuals with low blood pressure (systolic less than 100 mm Hg), arterial stiffening, pre-existing heart disease, or compromised kidney function. These patients require close observation while taking Carvitab 3.125 Tablet. Kidney function typically recovers to its initial state upon discontinuation of Carvitab 3.125 Tablet.
Diabetic individuals may use Carvitab 3.125 mg tablets, contingent upon consistent blood glucose monitoring. Studies indicate negligible impact on blood sugar in well-managed diabetes mellitus with mild to moderate hypertension. Nevertheless, beta-blockers, the class to which Carvitab 3.125 mg tablets belong, can mask hypoglycemic symptoms such as tachycardia, potentially delaying recognition of low blood sugar. Furthermore, in diabetic patients with heart failure, Carvitab 3.125 mg tablets might exacerbate hyperglycemia. Therefore, close blood glucose monitoring is crucial when starting, altering, or stopping Carvitab 3.125 mg tablet treatment. Report any blood glucose fluctuations to your physician during therapy.
Taking Carvitab 3.125 Tablet with food is advised. Food slows the medication's absorption, minimizing the risk of orthostatic hypotension—a drop in blood pressure leading to dizziness or fainting upon standing.
Taking Carvitab 3.125 mg tablets can lead to severe adverse reactions including dizziness, respiratory distress, increased body weight, and edema in the extremities. Other possible side effects are thoracic pain, bradycardia or arrhythmia, skin eruptions, urticaria, pruritus, and dysphagia. Seek immediate medical attention if any of these occur.
Exceeding the prescribed dosage of Carvitab 3.125 Tablet can result in bradycardia, vertigo, syncope, dyspnea, emesis, and potential loss of consciousness or convulsions. Immediate medical attention, including contacting your physician and seeking care at a local hospital, is crucial.
Patients with severe heart failure requiring intensive care unit admission or circulatory support via inotropic intravenous medications should not use Carvitab 3.125 Tablet. Furthermore, this medication is contraindicated for individuals with asthma or respiratory conditions, bradycardia or arrhythmias, hepatic impairment, or known allergies to Carvitab 3.125 Tablet.
Carvitab 3.125 Tablet
32
MRP 39
17% off